Lemaitre Vascular INC Form 4 insider transactions

Lemaitre Vascular Director John James O'Connor received restricted stock units and stock options as part of his compensation.

LEMAITRE VASCULAR Director Bridget Ross reported the acquisition of 533 common shares as restricted stock units and 3,431 stock options.

Lemaitre Vascular Director Martha Shadan was granted 533 restricted stock units and 3,431 stock options on December 10, 2025.

Lemaitre Vascular Director John Roush reported the acquisition of 533 restricted stock units and 3,431 stock options, increasing his beneficial ownership.

LeMaitre Vascular Inc.'s Chairman and CEO, George W. LeMaitre, reported routine beneficial ownership changes related to equity award vesting and tax withholding.

Lemaitre Vascular's President and Director, David B. Roberts, reported routine stock acquisitions from equity awards and dispositions for tax withholding.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported stock transactions related to RSU and PSU vesting, including tax-related share dispositions.

Lemaitre Vascular Director Joseph P. Pellegrino Jr. acquired 20 shares of common stock through the vesting of restricted and performance stock units.

Lemaitre Vascular Director Lawrence J. Jasinski acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Lemaitre Vascular Director John James O'Connor acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Bridget A Ross, a director at Lemaitre Vascular Inc., acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Lemaitre Vascular Director John A. Roush acquired five shares of common stock through the release of dividend equivalent rights tied to restricted and performance stock units.

Lemaitre Vascular Director Martha Shadan acquired 5 shares of common stock through the release of dividend equivalent rights.

A Lemaitre Vascular Senior VP reported routine acquisitions of common stock and dividend equivalent rights, alongside a tax-related sale of shares.

Lemaitre Vascular President and Director David B. Roberts reported routine transactions involving common stock and dividend equivalent rights.

LeMaitre Vascular's CFO, Dorian LeBlanc, acquired 2.8691 dividend equivalent rights, accruing on a restricted stock unit award.

Lemaitre Vascular Director Joseph P. Pellegrino JR acquired 3 shares of common stock through the release of dividend equivalent rights.

Lemaitre Vascular Director John James O'Connor reported a gift of 3,000 common shares and the acquisition of one share linked to dividend equivalent rights.

LeMaitre Vascular Director Lawrence J. Jasinski acquired one share of common stock through the release of dividend equivalent rights, increasing his direct beneficial ownership to 4,774 shares.

LeMaitre Vascular Director John Roush reported the acquisition of one common stock share and accrual of dividend equivalent rights through vesting awards.

LeMaitre Vascular Director Bridget A. Ross acquired 1 share of common stock through the vesting and release of dividend equivalent rights.

LeMaitre Vascular Director Martha Shadan reported the acquisition of common stock and dividend equivalent rights through vesting of equity awards.

LeMaitre Vascular CEO George W. LeMaitre disclosed routine stock acquisitions and dispositions related to equity awards and tax obligations.

LeMaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported the acquisition of 10 common shares from dividend equivalent rights and the disposition of 53 shares for tax withholding related to a restricted stock unit vesting.

LeMaitre Vascular Director Joseph P. Pellegrino Jr. acquired 15 shares of common stock through the vesting of restricted stock units and dividend equivalent rights.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, reported the acquisition of 45 shares and disposition of 455 shares of common stock on December 2, 2025, primarily related to RSU vesting and tax obligations.

LeMaitre Vascular President David B. Roberts reported the acquisition of 15 shares and disposition of 107 shares for tax obligations related to vested restricted stock units.

LeMaitre Vascular Director John O'Connor exercised options to acquire 7,500 shares of common stock, increasing his direct beneficial ownership.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, exercised options to acquire 2,681 shares of common stock at $41.02 per share.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., gifted 21,300 shares of common stock to an irrevocable trust for his children.